| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3871198 | The Journal of Urology | 2011 | 8 Pages |
Abstract
There is considerable heterogeneity in the treatment of patients with clinical T1a tumors. Several factors explain these differences as selected treatments are independently associated with tumor, patient and urologist factors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Rodney H. Breau, Paul L. Crispen, Sarah M. Jenkins, Michael L. Blute, Bradley C. Leibovich,